StockDriftsStockDriftsTop 50 Ikarian Capital LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 7.1% | 328.6K | $43.4M | +470.20%(+271.00K) | $104.91(+15.73%) | 2026-06-30 | |
| KOD | KODIAK SCIENCES INC | 6.76% | 1.06M | $41.3M | -16.28%(-206.06K) | $21.69(+90.60%) | 2026-06-30 | |
| ALMS | ALUMIS INC | 4.01% | 870.5K | $24.5M | -28.26%(-343.00K) | $15.90(+59.23%) | 2026-06-30 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 3.99% | 72.8K | $24.4M | +1.76%(+1.26K) | $129.86(+182.48%) | 2026-06-30 | |
| PCVX | VAXCYTE INC | 3.7% | 388.7K | $22.6M | -9.33%(-40.00K) | $41.82(+38.85%) | 2026-06-30 | |
| ANIP | ANI PHARMACEUTICALS INC | 3.69% | 272.1K | $22.5M | +84.98%(+125.00K) | $78.07(-1.96%) | 2026-06-30 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2.91% | 478.5K | $17.8M | +3.74%(+17.25K) | $29.58(+41.81%) | 2026-06-30 | |
| RCUS | ARCUS BIOSCIENCES INC | 2.55% | 504.6K | $15.6M | new | $22.73(+29.70%) | 2026-06-30 | |
| RLMD | RELMADA THERAPEUTICS INC | 2.43% | 2.15M | $14.9M | -20.09%(-540.00K) | $2.45(+95.53%) | 2026-06-30 | |
| CAPR | CAPRICOR THERAPEUTICS INC | 2.38% | 604.2K | $14.5M | +14.43%(+76.20K) | $15.81(-57.94%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +12.49% | +42.33% | -0.45% | -2.22% |
| Top 20 Holdings Unweighted | +17.03% | +60.30% | +5.50% | +30.68% |
Ikarian Capital LLC reports $928.17M in US-listed equity holdings across 126 positions in its most recent 13F filing. Its largest disclosed positions are ABVX (7.1%), KOD (6.8%) and ALMS (4.0%). The top 20 holdings account for 58.9% of reported assets. Its disclosed equity book has returned +42.33% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Ikarian Capital LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ikarian Capital LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1778253). View Ikarian Capital LLC’s 13F filings on SEC